Company
Haleon plc
Headquarters: Weybridge, United Kingdom
Founded: 18 July 2022
CEO: Brian McNamara
Market Cap
£33.59 Billion
GBP as of Jan. 1, 2025
US$42.16 Billion
Company Description
Haleon plc, headquartered in Brentford, UK, specializes in the R&D, manufacture, and sale of consumer healthcare products across various regions. Their offerings encompass therapeutic oral health, pain relief, respiratory, digestive products, and vitamins and supplements. Key brands include Panadol, Voltaren, Advil, Sensodyne, and Centrum.
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | June 30, 2024 |
| Revenue TTM | £11.24 B |
| EBITDA | £2.08 B |
| Gross Profit TTM | £6.99 B |
| Profit Margin | 10.75% |
| Operating Margin | 25.36% |
| Quarterly Revenue Growth | -0.60% |
Stocks & Indices
Haleon plc has the following listings and related stock indices.
Stock: LSE: HLN wb_incandescent
Stock: NYSE: HLN wb_incandescent
Product & Services
Oral hygiene and medicines, nutritional products, over-the-counter medicines